A novel, selective and orally-available glucosylceramide synthase inhibitor for substrate reduction therapy of Fabry disease
Molecular Genetics and Metabolism(2013)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Molecular Genetics and Metabolism(2013)